Symbol List Views
Stock Details
CHARTS
COMPANY NEWS
STOCK ANALYSIS
FUNDAMENTALS
HOLDINGS
Edit Symbol List
Symbol Lookup
GILD: Stock Quote & Summary Data
0.68%
| Last Sale | |
| Change Net / % |
|
| Best Bid / Ask | |
| 1y Target Est: | $ 55.00 |
| Today's High / Low | / |
| Share Volume | |
| 50 Day Avg. Daily Volume | 9,214,427 |
| Previous Close | $ 46.09 |
| 52 Wk High / Low | $ 52.29 / $ 40.62 |
| Shares Outstanding | 899,925,000 |
| Market Value | $ 41,761,019,625 |
| P/E Ratio | 15.16 |
| Forward P/E (1yr) | 11.54 |
| Earnings Per Share | $ 3.06 |
| Annualized Dividend | N/A |
| Ex Dividend Date | N/A |
| Dividend Payment Date | N/A |
| Current Yield | N/A |
| Beta | 0.54 |
| NASDAQ Official Open Price: | $ 46.57 |
| Date of NASDAQ Official Open Price: | Feb. 9, 2010 |
| NASDAQ Official Close Price: | $ 46.09 |
| Date of NASDAQ Official Close Price: | Feb. 8, 2010 |
Intraday Chart |
| 5d | 1m | 6m | 12m | More Charting |
Have a Question About GILD?
Ask your question about about Gilead Sciences, Inc. (GILD) by typing it in the box below. You'll get direct responses from other members of the NASDAQ Answers community!
Hot Topics in NASDAQ Answers
The most popular questions & answers in the
NASDAQ Answers Community:
Company Description (as filed with the SEC)
Gilead Sciences, Inc. (Gilead, we, us or our), incorporated in Delaware on June 22, 1987, is a biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need. Our mission is to advance the care of patients suffering from life-threatening diseases worldwide. Headquartered in Foster City, California, we have operations in North America, Europe and Australia. To date, we have focused our efforts on bringing novel therapeutics for the treatment of life-threatening diseases to market. We continue to seek to add to our existing portfolio of products through our internal discovery and clinical development programs and through an active product acquisition and in-licensing strategy. ... More ...
Links to all Gilead Sciences, Inc. (GILD) Pages
Stock Analysis
Fundamentals
Holdings/Ownership
Company News for GILD |
||
|
Gilead Sciences To Present At The 12th Annual BIO CEO Investor Conference At 10:00 AM, ET - RTT News 02/09/2010 8:50AM |
||
|
Cramer's Lightning Round - I Like Nike (2/8/10) - Seeking Alpha 02/09/2010 4:49AM |
||
|
'Mad Money Lightning Round': Visa Rocks - TheStreet 02/08/2010 7:33PM |
||
|
Cramer's 'Mad Money' Recap: The Lure of Semiconductor Stocks (Final) - TheStreet 02/08/2010 7:24PM |
||
|
Director William Furman Buys $2.1M Worth of Schnitzer Steel - TheStreet 02/08/2010 10:58AM |
Consensus Recommendation |
|
Analyst Info |
|
| Annual EPS Est: | $ 3.57 |
| Quarterly EPS Est: | $ 0.91 |
| PEG Ratio: | 0.90 |
| Mean Recommendation: View Summary/View All |
1.90 |
